KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Oct 26, 2023 $1.16 $1.21 $1.10 $1.13 262 565
Oct 25, 2023 $1.22 $1.25 $1.17 $1.17 321 877
Oct 24, 2023 $1.30 $1.31 $1.23 $1.27 164 600
Oct 23, 2023 $1.35 $1.38 $1.23 $1.28 187 455
Oct 20, 2023 $1.38 $1.44 $1.33 $1.33 363 565
Oct 19, 2023 $1.35 $1.41 $1.31 $1.34 210 869
Oct 18, 2023 $1.35 $1.38 $1.27 $1.34 218 537
Oct 17, 2023 $1.25 $1.38 $1.25 $1.35 324 328
Oct 16, 2023 $1.25 $1.28 $1.21 $1.21 141 823
Oct 13, 2023 $1.23 $1.25 $1.20 $1.25 68 301
Oct 12, 2023 $1.27 $1.27 $1.20 $1.20 99 416
Oct 11, 2023 $1.27 $1.31 $1.24 $1.25 108 929
Oct 10, 2023 $1.23 $1.27 $1.23 $1.25 51 420
Oct 09, 2023 $1.24 $1.30 $1.22 $1.22 143 441
Oct 06, 2023 $1.24 $1.30 $1.19 $1.28 239 517
Oct 05, 2023 $1.23 $1.27 $1.19 $1.23 220 033
Oct 04, 2023 $1.23 $1.23 $1.18 $1.22 125 216
Oct 03, 2023 $1.24 $1.26 $1.20 $1.24 162 763
Oct 02, 2023 $1.27 $1.31 $1.22 $1.25 114 286
Sep 29, 2023 $1.30 $1.33 $1.25 $1.29 58 347
Sep 28, 2023 $1.30 $1.34 $1.26 $1.28 39 255
Sep 27, 2023 $1.26 $1.29 $1.26 $1.27 88 023
Sep 26, 2023 $1.25 $1.32 $1.25 $1.26 72 984
Sep 25, 2023 $1.26 $1.28 $1.22 $1.26 169 978
Sep 22, 2023 $1.30 $1.34 $1.27 $1.28 298 934
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT